Imaging of Parotid Tumours and Cancers

Minority of parotid tumours require imaging

  • Only required if it might change management
  • Infrequently indicated for clinically benign, mobile parotid tumours as it rarely alters surgical management

Indications

  • Suspect non-neoplastic disease e.g. HIV lymphoepithelial cyst, TB, benign cyst, lipoma (US / CT)
  • Deep vs superficial lobe parotid tumour
  • Mobile tumour: Only if surgeon does not have skill to resect a deep lobe tumour (CT with contrast / MRI)
  • Reduced mobility/fixed tumour
  • Deep lobe tumour (CT with contrast / MRI)
  • Extension to parapharyngeal space (CT with contrast / MRI)
  • Invasion of local structures (CT / MRI)
  • Recurrence of benign or malignant tumours (MRI)
  • Neurological deficits e.g. facial nerve to determine extent of perineural invasion (MRI with Gd)
  • Metastases to parotid gland (skin, conjunctiva), to plan selective vs therapeutic neck dissection (US / CT / MRI)
  • Exclude lung metastases with suspected/known malignancy (CXR / CT)

Types of imaging

  • Ultrasound
    • Cystic vs solid; associated cervical lymph nodes
    • Not good for deep vs superficial lobe, or for parapharyngeal extension
  • CT with contrast
    • Cystic vs solid; associated cervical lymph nodes
    • Deep vs superficial lobe mass, or for parapharyngeal extension (Need to identify retromandibular vein (Need to identify retromandibular vein)
  • MRI
    • Tumour “stuck” around stylomastoid foramen area
    • Local invasion (Good soft tissue differentiation)
    • Deep vs superficial lobe mass, or for parapharyngeal extension
    • Perineural invasion

PET-CT: Unhelpful as benign pathology (pleomorphic adenoma, Warthin tumours, TB, abscesses, lymphoma) are PET-avid

Index: Clinical Practice Guidelines for Parotid

Resource Appropriate Parotid Guideline Scenarios